Results 81 to 90 of about 3,061 (175)

Revisiting Digitalis in Heart Failure: Lessons From DIGIT-HF and Beyond. [PDF]

Circulation
Tarabanis C, Khurshid S, Givertz MM.
europepmc   +1 more source

The comeback of digitalis (digitoxin): the DIGIT-HF trial. [PDF]

Eur Heart J Suppl
Sciatti E, D'Elia E, Gori M, Fazzini L, D'Isa S, Di Odoardo LAF, Zucchetti O, Iacovoni A, Senni M, Gavazzi A.   +9 more
europepmc   +1 more source

Digitoxin in heart failure: a statistical signal, or just noise? A reappraisal of the DIGIT-HF trial. [PDF]

Eur Heart J Cardiovasc Pharmacother
Abdelaziz A, Tanboga IH, Fonarow GC.
europepmc   +1 more source

An old drug in a new era: digitoxin in the spotlight after DIGIT-HF. [PDF]

Eur Heart J Cardiovasc Pharmacother
Gragnano F, Galli M, Calabrò P, Dobrev D.   +3 more
europepmc   +1 more source

Elucidating the Complex Structural and Molecular Mechanisms Driving P-Glycoprotein-Mediated Transport of Cardiac Glycosides. [PDF]

Int J Mol Sci
Katti R, Kozarich AM, Mensah GAK, Bartlett MG.   +3 more
europepmc   +1 more source

Radioimmunoassay of Digoxin and Digitoxin

Clinical Chemistry, 1975
H R, Besch, A M, Watanabe
openaire   +2 more sources

Proteome mining of Yersinia Enterocolitica for drug targets and computational inhibitor identification with ADMET, anti-inflammation potential and formulation characteristics. [PDF]

BioData Min
Basharat Z, Alghamdi YS, Mashraqi MM, Ogaly HA, Al-Zahrani FAM, Wei CR, Ahmed I, Kim S.   +7 more
europepmc   +1 more source

Heart failure in the elderly: epidemiology, mechanisms, and management. [PDF]

Eur Heart J
de Boer RA, Abdellatif M, Bauersachs J, Roger VL.   +3 more
europepmc   +1 more source

DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT-HF): Baseline characteristics compared to recent randomized controlled heart failure trials. [PDF]

Eur J Heart Fail
Bavendiek U, Thomas NH, Berliner D, Liu X, Schwab J, Rieth A, Maier LS, Schallhorn S, Angelini E, Soltani S, Rathje F, Sandu MA, Geller W, Gaspar T, Hambrecht R, Zdravkovic M, Philipp S, Kosevic D, Nickenig G, Scheiber D, Winkler S, Becher PM, Lurz P, Hülsmann M, von Karpowitz M, Schröder C, Neuhaus B, Seltmann A, von der Leyen H, Veltmann C, Störk S, Böhm M, Koch A, Großhennig A, Bauersachs J, DIGIT‐HF Study Group.   +35 more
europepmc   +1 more source

Repurposing acetyldigitoxin as a potential EZH2 inhibitor for non-small cell lung cancer: a computational and experimental approach. [PDF]

J Comput Aided Mol Des
Ji X, Wang X, Xiu T, Gao M, Lu D.
europepmc   +1 more source